FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s health risks and long history - theconversation.com
FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s health risks and long history - theconversation.com — FDA update affecting Pharmaceutical Manufacturing (FDA/DEA).
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 13, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmaceutical Manufacturing (FDA/DEA) (branded drug makers) should confirm how it applies to their specific situation before acting. There is a time constraint attached: as soon as possible. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA bans Red 3 dye from food and drugs – a scientist explains the artificial color’s health risks and long history - theconversation.com
Who it affects
Pharmaceutical Manufacturing (FDA/DEA) (branded drug makers)
What you must do
Review the new rule now and confirm your operation stays compliant to avoid penalties or loss of standing in Pharmaceutical Manufacturing (FDA/DEA).
Deadline
as soon as possible
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Breaking the Ice: FDA-focused firm leader sees benefits in AI | Gardner Law - JD Supra
- Interview with FDA Press Officer Charles Kohler from CDER - Cleanroom Technology
- Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels
- Expert sees shift to ‘ecosystem-centric assurance’ under FDA’s distributed manufacturing rule - raps.org
- LGM Pharma to Invest Over $6M to Expand Rosenberg Facility - contractpharma.com